← SynDRA
ILOMASTAT
SynDRA canonical compound SYN0001168 — structure-anchored drug synonym record
Clinical phase
Phase 3
Primary target(s)
ACAN | ADAM28 | MMP1 | MMP12 | MMP13 | MMP14 | MMP2 | MMP3 | MMP8 | MMP9
Mechanism of action
matrix metalloprotease inhibitor
All known targets
MMP1
MMP12
MMP13
MMP14
MMP2
MMP3
MMP8
MMP9
ACAN
ADAM28
Bact lef
MMP21
Mechanisms of action (all sources)
matrix metalloprotease inhibitor
MMP1 INHIBITOR
Inhibitor
MMP21 INHIBITOR
MMP14 INHIBITOR
MMP8 INHIBITOR
MMP2 INHIBITOR
MMP3 INHIBITOR
MMP9 INHIBITOR
MMP12 INHIBITOR
MMP13 INHIBITOR
Cross-references
PubChem CID:
132519
ChEMBL:
CHEMBL19611
DrugBank:
DB02255
ChEBI:
137236
KEGG:
D03793
PDB:
GM6
Wikipedia:
Ilomastat
TTD: D0T9HG
LINCS BRD: BRD-K51662849
Synonyms
Galardin
Gm6001
GM6001
GM-6001
Illomastat
CS 610
UNII-I0403ML141
CHEMBL19611
Ilomastat (GM6001, Galardin)
I0403ML141
NCGC00163450-02
3-(N-HYDROXYCARBOXAMIDO)-2-ISOBUTYLPROPANOYL-TRP-METHYLAMIDE
(R)-N4-Hydroxy-N1-[(S)-2-(1H-indol-3-yl)-1-methylcarbamoyl-ethyl]-2-isobutyl-succinamide
N-[(2R)-2-(Hydroxamidocarbonylmethyl)-4-methylpentanoyl]-L-tryptophan Methylamide
(R)-N(sup 1)-Hydroxy-N-((S)-2-indol-3-yl-1-(methylcarbamoyl)ethyl)-2-isobutylsuccinamide
(S-(R*,S*))-N(sup 4)-Hydroxy-N(sup
CS-610
(R)-N1-((S)-3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl)-N4-hydroxy-2-isobutylsuccinamide
(S-(R*,S*))-N(sup 4)-Hydroxy-N(sup 1)-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl)-2-(2-methylopropyl)butanediamide
Ilomastat [USAN]
Galardin MPI
(2R)-N'-hydroxy-N-[(2S)-3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl]-2-(2-methylpropyl)butanediamide
Ilomastat (USAN/INN)
Ilomastat [USAN:INN]
4pkw
GM6
MFCD03453614
ILOMASTAT [INN]
ILOMASTAT [INCI]
Ilomastat; GM-6001
GM6001;Galardin;Ilomastat
CBiol_001883
SCHEMBL35303
BSPBio_001079
KBioGR_000419
KBioSS_000419
GTPL7409
DTXSID0046353
Look up ILOMASTAT in the interactive SynDRA portal →